Literature DB >> 9540797

Measurement of peptide aggregation with pulsed-field gradient nuclear magnetic resonance spectroscopy.

S L Mansfield1, D A Jayawickrama, J S Timmons, C K Larive.   

Abstract

Interactions between hydrophobic patches in proteins are often a driving force for denaturation and aggregation. The aggregation of the beta-amyloid peptide fragment, VHHQKLVFFAEDVGSNK (beta(12-28)), has been investigated in aqueous solution at low pH. This peptide contains a central hydrophobic patch spanning residues 17-21. Diffusion coefficients measured with pulsed-field gradient NMR as a function of peptide solution concentration were used to assess the extent of aggregation. Following the hypothesis that hydrophobic interactions are an important driving force in the aggregation of this peptide at low pH, a non-aggregating analog of the beta(12-28) peptide, [Gly19,20]beta(12-28) was synthesized. In the [Gly19,20]beta(12-28) peptide, the replacement of the two phenylalanine residues disrupts the hydrophobic interactions which drive the aggregation of beta(12-28). The diffusion coefficient of the [Gly19,20]beta(12-28) peptide is invariant over the concentration range studied and provides a good estimate of the monomeric diffusion coefficient of beta(12-28). A second peptide analog was synthesized in which the phenylalanine at position 20 was replaced with a cysteine residue. The disulfide-linked dimer, ([Cys20]beta(12-28))2, was formed upon air oxidation of this peptide. The diffusion coefficient of the ([Cys20]beta(12-28))2 peptide was measured and used to estimate the diffusion coefficient of the beta(12-28) dimer. Using the monomeric and dimeric diffusion coefficients measured for the glycine and cysteine analogs, the concentration dependence of the beta(12-28) diffusion coefficient was found to be consistent with a monomer-dimer aggregation model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540797     DOI: 10.1016/s0167-4838(97)00162-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Protein-ligand interactions measured by 15N-filtered diffusion experiments.

Authors:  M L Tillett; M A Horsfield; L Y Lian; T J Norwood
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

2.  Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

Authors:  Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

3.  Aβ association inhibition by transferrin.

Authors:  Annie V Raditsis; Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

4.  Protein conformational changes studied by diffusion NMR spectroscopy: application to helix-loop-helix calcium binding proteins.

Authors:  Aalim M Weljie; Aaron P Yamniuk; Hidenori Yoshino; Yoshinobu Izumi; Hans J Vogel
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

5.  Reversibility of beta-amyloid self-assembly: effects of pH and added salts assessed by fluorescence photobleaching recovery.

Authors:  Nadia J Edwin; Robert P Hammer; Robin L McCarley; Paul S Russo
Journal:  Biomacromolecules       Date:  2010-02-08       Impact factor: 6.988

6.  Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide.

Authors:  Jessica A Williamson; J Patrick Loria; Andrew D Miranker
Journal:  J Mol Biol       Date:  2009-07-30       Impact factor: 5.469

7.  Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease.

Authors:  Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

8.  Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria.

Authors:  Virender Singh; Ratan Kumar Rai; Ashish Arora; Neeraj Sinha; Ashwani Kumar Thakur
Journal:  Sci Rep       Date:  2014-01-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.